Literature DB >> 10508189

The Ig heavy chain intronic enhancer core region is necessary and sufficient to promote efficient class switch recombination.

E Sakai1, A Bottaro, F W Alt.   

Abstract

The intronic IgH enhancer E(mu), which consists of the core enhancer (cE(mu) flanked by 5' and 3' matrix attachment regions (MAR), has been implicated in the control of IgH locus recombination and transcription. Both cE(mu) and the MAR are required to enhance transcription of an IgH transgene. To elucidate the regulatory functions of cE(mu) versus its associated MAR in IgH class switch recombination (CSR), we have assayed ES cell lines which have targeted deletions of these elements, both individually and in combination, by the Rag-2-deficient blastocyst complementation method. Mutant B cells from chimeric mice were activated in culture and the influence of the mutations on CSR was assessed by analysis of B cell hybridomas. We find that the cE(mu) is necessary and sufficient for providing the functions of E(mu) required for efficient CSR at the IgH locus. However, the 5' and 3' MAR sequences, as well as the known I(mu) transcription start sites and the bulk of I(mu) coding sequences, were dispensable for the process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508189     DOI: 10.1093/intimm/11.10.1709

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  16 in total

1.  Transcriptional activation by LR1 at the Emu enhancer and switch region sites.

Authors:  L A Hanakahi; N Maizels
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

2.  Elucidation of IgH intronic enhancer functions via germ-line deletion.

Authors:  Thomas Perlot; Frederick W Alt; Craig H Bassing; Heikyung Suh; Eric Pinaud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

3.  Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.

Authors:  Hong Duan; Caroline A Heckman; Linda M Boxer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

4.  Requirement for enhancer specificity in immunoglobulin heavy chain locus regulation.

Authors:  Igor I Kuzin; Ludmila Bagaeva; Faith M Young; Andrea Bottaro
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

5.  Immunoglobulin G locus events in soft tissue sarcoma cell lines.

Authors:  Zhengshan Chen; Jing Li; Yanna Xiao; Junjun Zhang; Yingying Zhao; Yuxuan Liu; Changchun Ma; Yamei Qiu; Jin Luo; Guowei Huang; Christine Korteweg; Jiang Gu
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

6.  Binding of estrogen receptors to switch sites and regulatory elements in the immunoglobulin heavy chain locus of activated B cells suggests a direct influence of estrogen on antibody expression.

Authors:  Bart G Jones; Rhiannon R Penkert; Beisi Xu; Yiping Fan; Geoff Neale; Patricia J Gearhart; Julia L Hurwitz
Journal:  Mol Immunol       Date:  2016-08-03       Impact factor: 4.407

7.  Comparison of identical and functional Igh alleles reveals a nonessential role for Eμ in somatic hypermutation and class-switch recombination.

Authors:  Fubin Li; Yi Yan; Joyce Pieretti; Danielle A Feldman; Laurel A Eckhardt
Journal:  J Immunol       Date:  2010-10-11       Impact factor: 5.422

8.  S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase.

Authors:  Robert Wuerffel; Lili Wang; Fernando Grigera; John Manis; Erik Selsing; Thomas Perlot; Frederick W Alt; Michel Cogne; Eric Pinaud; Amy L Kenter
Journal:  Immunity       Date:  2007-11-01       Impact factor: 31.745

Review 9.  Mechanism and regulation of class switch recombination.

Authors:  Janet Stavnezer; Jeroen E J Guikema; Carol E Schrader
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

10.  Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region.

Authors:  Wesley A Dunnick; John T Collins; Jian Shi; Gerwin Westfield; Clinton Fontaine; Paul Hakimpour; F Nina Papavasiliou
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.